000919.SZ

Jinling Pharmaceutical Company Limited [000919.SZ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

000919.SZ Stock Summary

Top 10 Correlated ETFs

000919.SZ


Top 10 Correlated Stocks

000919.SZ


In the News

000919.SZ Financial details

Company Rating
Buy
Market Cap
3.45B
Income
106.07M
Revenue
2.72B
Book val./share
6.04
Cash/share
2.31
Dividend
0.1
Dividend %
1.28%
Employees
4.88K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
37.23
Forward P/E
16.32
PEG
-30.81
P/S
1.45
P/B
1.3
P/C
2.9
P/FCF
-20.53
Quick Ratio
2.25
Current Ratio
2.85
Debt / Equity
0
LT Debt / Equity
0
-
-
EPS (TTM)
0.21
EPS next Y
0.41
EPS next Q
-
EPS this Y
-12.5%
EPS next Y
94.31%
EPS next 5Y
94.31%
EPS last 5Y
-15.24%
Revenue last 5Y
-1.63%
Revenue Q/Q
-9.55%
EPS Q/Q
-40.71%
-
-
-
-
SMA20
1.19%
SMA50
-14.57%
SMA100
-14.79%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
3%
ROC
0.03%
Gross Margin
20%
Oper. Margin
5%
Profit Margin
4%
Payout
48%
Shs Outstand
504M
Shs Float
204.66M
-
-
-
-
Target Price
-
52W Range
5.38-10.13
52W High
-33.1%
52W Low
+33.8%
RSI
45.14
Rel Volume
0.38
Avg Volume
8.97M
Volume
3.41M
Perf Week
-4.84%
Perf Month
8.08%
Perf Quarter
-
Perf Half Y
-17.41%
-
-
-
-
Beta
0.488
-
-
Volatility
0.13%, 0.17%
Prev Close
0.3%
Price
6.69
Change
1.67%

000919.SZ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
5.755.034.975.575.3
Net income per share
0.480.290.190.240.21
Operating cash flow per share
0.860.920.620.580.52
Free cash flow per share
0.590.670.040.26-0.1
Cash per share
2.023.132.612.983.15
Book value per share
5.435.715.675.815.94
Tangible book value per share
5.726.276.396.76.63
Share holders equity per share
5.435.715.675.815.94
Interest debt per share
0.010.060.080.030.01
Market cap
3.1B3.68B3.88B3.86B3.92B
Enterprise value
2.14B2.25B2.6B2.37B2.43B
P/E ratio
12.8425.3241.3831.9637.19
Price to sales ratio
1.071.451.551.371.47
POCF ratio
7.167.912.4413.215.03
PFCF ratio
10.4410.82193.2429.83-79.83
P/B Ratio
1.131.281.361.321.31
PTB ratio
1.131.281.361.321.31
EV to sales
0.740.891.040.840.91
Enterprise value over EBITDA
4.414.858.667.5811.08
EV to operating cash flow
4.934.828.358.129.31
EV to free cash flow
7.196.6129.6318.34-49.46
Earnings yield
0.080.040.020.030.03
Free cash flow yield
0.10.090.010.03-0.01
Debt to equity
00.010.010.010
Debt to assets
00.010.0100
Net debt to EBITDA
-1.99-3.1-4.25-4.75-6.8
Current ratio
3.73.322.562.673.04
Interest coverage
137.31798.72470.25673.8370.18
Income quality
1.52.543.331.912.29
Dividend Yield
0.040.020.020.010.01
Payout ratio
0.530.590.960.420.49
Sales general and administrative to revenue
0.030.030.030.030.03
Research and developement to revenue
0.010.020.020.020.03
Intangibles to total assets
0.090.060.050.040.06
Capex to operating cash flow
-0.31-0.27-0.94-0.56-1.19
Capex to revenue
-0.05-0.05-0.12-0.06-0.12
Capex to depreciation
-1.11-1.03-2.43-1.32-2.49
Stock based compensation to revenue
00000.01
Graham number
7.666.094.875.595.28
ROIC
0.110.090.050.050.03
Return on tangible assets
0.070.040.020.030.02
Graham Net
1.852.541.892.212.35
Working capital
1.64B1.57B1.25B1.43B1.77B
Tangible asset value
2.88B3.16B3.22B3.38B3.34B
Net current asset value
1.61B1.51B1.2B1.38B1.72B
Invested capital
00.010.010.010
Average receivables
634.95M506.01M467.23M520.32M525.84M
Average payables
287.67M288.45M401.03M472.57M466.7M
Average inventory
326.52M235.26M224.71M230.46M247.98M
Days sales outstanding
73.2361.9773.4969.7270.39
Days payables outstanding
39.8763.3887.5380.3177.34
Days of inventory on hand
39.244.140.4841.1342.67
Receivables turnover
4.985.894.975.235.19
Payables turnover
9.155.764.174.544.72
Inventory turnover
9.318.289.028.888.55
ROE
0.090.050.030.040.04
Capex per share
-0.27-0.25-0.58-0.32-0.61

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.381.261.411.451.32
Net income per share
0.070.020.090.070.04
Operating cash flow per share
0.070.020.090.06-0.03
Free cash flow per share
0.01-0.210-0.02-0.16
Cash per share
33.253.0232.31
Book value per share
5.896.126.036.16.04
Tangible book value per share
6.596.836.736.816.75
Share holders equity per share
5.896.126.036.16.04
Interest debt per share
00.010.010.010.01
Market cap
3.43B3.8B3.91B3.94B4.15B
Enterprise value
2.29B2.31B2.65B2.7B3.24B
P/E ratio
25.45112.2522.4329.0551.65
Price to sales ratio
4.896.165.525.386.26
POCF ratio
101.8449.0189.71125.06-305.63
PFCF ratio
1.02K-36.642.52K-323.96-53.1
P/B Ratio
1.141.271.291.281.36
PTB ratio
1.141.271.291.281.36
EV to sales
3.273.743.753.684.89
Enterprise value over EBITDA
81.2-73.3344.5560.63120.5
EV to operating cash flow
68.03272.9260.985.58-238.76
EV to free cash flow
681.3-22.271.71K-221.68-41.48
Earnings yield
0.0100.010.010
Free cash flow yield
0-0.0300-0.02
Debt to equity
00000
Debt to assets
00000
Net debt to EBITDA
-40.3147.31-21.07-27.97-33.75
Current ratio
2.83.043.273.362.85
Interest coverage
830.2127.344.52K470.12552.55
Income quality
1110.93-0.68
Dividend Yield
0.010000.01
Payout ratio
1.51000.022.51
Sales general and administrative to revenue
0.27-0.240.11-0.050.3
Research and developement to revenue
0.040.050.020.020.02
Intangibles to total assets
0.060.060.060.060.06
Capex to operating cash flow
-0.9-13.26-0.96-1.394.76
Capex to revenue
-0.04-0.18-0.06-0.06-0.1
Capex to depreciation
-0.85-3.14-1.24-1.281.02
Stock based compensation to revenue
00000
Graham number
2.961.543.433.042.33
ROIC
0.010.030.020.010.01
Return on tangible assets
0.0100.010.010
Graham Net
2.372.422.442.511.86
Working capital
1.54B1.77B1.82B1.88B1.5B
Tangible asset value
3.36B3.34B3.39B3.43B3.4B
Net current asset value
1.49B1.72B1.77B1.83B1.46B
Invested capital
00000
Average receivables
633.03M573.13M547.12M610.97M657.88M
Average payables
452.99M459.44M451.56M438.64M438.2M
Average inventory
225.3M238.69M240.65M233.85M248.98M
Days sales outstanding
80.9575.1373.5678.9491.37
Days payables outstanding
75.1177.9972.2667.6576.69
Days of inventory on hand
36.6643.0337.1437.4344.67
Receivables turnover
1.111.21.221.140.99
Payables turnover
1.21.151.251.331.17
Inventory turnover
2.452.092.422.42.01
ROE
0.0100.010.010.01
Capex per share
-0.06-0.23-0.08-0.09-0.13

000919.SZ Frequently Asked Questions

What is Jinling Pharmaceutical Company Limited stock symbol ?

Jinling Pharmaceutical Company Limited is a CN stock and trading under the symbol 000919.SZ

What is Jinling Pharmaceutical Company Limited stock quote today ?

Jinling Pharmaceutical Company Limited stock price is $6.69 today.

Is Jinling Pharmaceutical Company Limited stock public?

Yes, Jinling Pharmaceutical Company Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs